25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TegoScience Inc
Buy, Hold or Sell?

Let's analyze Tegoscience together

I guess you are interested in TegoScience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TegoScience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about TegoScience Inc

I send you an email if I find something interesting about TegoScience Inc.

1. Quick Overview

1.1. Quick analysis of Tegoscience (30 sec.)










1.2. What can you expect buying and holding a share of Tegoscience? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
3.3%

What is your share worth?

Current worth
₩6,271.12
Expected worth in 1 year
₩6,702.94
How sure are you?
56.7%

+ What do you gain per year?

Total Gains per Share
₩431.82
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
₩15,120.00
Expected price per share
₩10,710 - ₩19,000
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Tegoscience (5 min.)




Live pricePrice per Share (EOD)
₩15,120.00

2.2. Growth of Tegoscience (5 min.)




Is Tegoscience growing?

Current yearPrevious yearGrowGrow %
How rich?$35.4m$33.6m-$463.4k-1.4%

How much money is Tegoscience making?

Current yearPrevious yearGrowGrow %
Making money$586.6k-$227.7k$814.3k138.8%
Net Profit Margin39.0%-16.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Tegoscience (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Tegoscience?

Welcome investor! Tegoscience's management wants to use your money to grow the business. In return you get a share of Tegoscience.

First you should know what it really means to hold a share of Tegoscience. And how you can make/lose money.

Speculation

The Price per Share of Tegoscience is ₩15,120. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tegoscience.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tegoscience, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩6,271.12. Based on the TTM, the Book Value Change Per Share is ₩107.96 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-38.90 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tegoscience.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.430.0%0.070.0%-0.030.0%0.020.0%0.000.0%
Usd Book Value Change Per Share0.430.0%0.080.0%-0.030.0%0.010.0%0.150.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.430.0%0.080.0%-0.030.0%0.010.0%0.150.0%
Usd Price Per Share13.50-11.36-9.03-14.15-24.76-
Price to Earnings Ratio7.93-29.78--83.61-46.32-121.09-
Price-to-Total Gains Ratio31.47-67.18--2,868.50--503.35--169.01-
Price to Book Ratio3.07-2.76-2.16-3.39-7.13-
Price-to-Total Gains Ratio31.47-67.18--2,868.50--503.35--169.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.584
Number of shares94
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.080.01
Usd Total Gains Per Share0.080.01
Gains per Quarter (94 shares)7.101.37
Gains per Year (94 shares)28.415.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10281805-5
2057460110
3085740165
4011410202210
5014213002715
6017015803320
7019918603825
8022721404430
9025624204935
10028427005540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%12.08.00.060.0%18.011.01.060.0%18.011.01.060.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%10.09.01.050.0%17.012.01.056.7%17.012.01.056.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.029.03.3%1.00.029.03.3%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%10.09.01.050.0%17.012.01.056.7%17.012.01.056.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of TegoScience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--612.619107.955+467%-38.898+106%20.807+2844%209.037+193%
Book Value Per Share--6271.1165879.842+7%5961.842+5%5949.782+5%5595.621+12%
Current Ratio--14.93212.425+20%10.095+48%17.690-16%18.450-19%
Debt To Asset Ratio--0.0480.054-12%0.058-18%0.041+15%0.085-44%
Debt To Equity Ratio--0.0500.057-13%0.062-19%0.043+15%0.128-61%
Dividend Per Share----0%-0%0.001-100%0.001-100%
Eps--607.574103.790+485%-40.292+107%29.319+1972%-0.989+100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.967+3%
Market Cap122088405600.000-28%155678866400.000131010871750.000+19%104182913575.000+49%163189950915.000-5%285589163310.000-45%
Net Profit Margin--2.5860.390+564%-0.160+106%0.093+2673%-0.017+101%
Operating Margin----0%-0.0070%0.021-100%0.044-100%
Operating Ratio--0.5771.405-59%1.071-46%0.688-16%0.768-25%
Pb Ratio2.411-28%3.0742.763+11%2.163+42%3.393-9%7.133-57%
Pe Ratio6.221-28%7.93329.783-73%-83.609+1154%46.321-83%121.089-93%
Price Per Share15120.000-28%19280.00016225.000+19%12902.500+49%20208.000-5%35367.000-45%
Price To Free Cash Flow Ratio----154.8810%-15.2460%54.855-100%91.697-100%
Price To Total Gains Ratio24.681-28%31.47167.182-53%-2868.504+9215%-503.345+1699%-169.013+637%
Quick Ratio---6.957-100%13.205-100%17.091-100%14.772-100%
Return On Assets--0.0920.015+512%-0.006+107%0.004+1993%0.000+101%
Return On Equity--0.0970.016+514%-0.007+107%0.005+2023%-0.001+101%
Total Gains Per Share--612.619107.955+467%-38.898+106%20.807+2844%209.038+193%
Usd Book Value--35445858.70033234285.044+7%33697768.589+5%33632629.769+5%31630101.914+12%
Usd Book Value Change Per Share--0.4290.076+467%-0.027+106%0.015+2844%0.146+193%
Usd Book Value Per Share--4.3904.116+7%4.173+5%4.165+5%3.917+12%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps--0.4250.073+485%-0.028+107%0.021+1972%-0.001+100%
Usd Free Cash Flow----197659.3970%-298467.4750%10396.646-100%-347207.1690%
Usd Market Cap85461883.920-28%108975206.48091707610.225+19%72928039.503+49%114232965.641-5%199912414.317-45%
Usd Price Per Share10.584-28%13.49611.358+19%9.032+49%14.146-5%24.757-45%
Usd Profit--3434152.400586646.748+485%-227737.578+107%165731.605+1972%-5577.972+100%
Usd Revenue--1328166.0001220484.697+9%1423484.934-7%1374243.159-3%1366140.401-3%
Usd Total Gains Per Share--0.4290.076+467%-0.027+106%0.015+2844%0.146+193%
 EOD+3 -4MRQTTM+22 -4YOY+21 -55Y+19 -1210Y+22 -9

3.3 Fundamental Score

Let's check the fundamental score of TegoScience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.221
Price to Book Ratio (EOD)Between0-12.411
Net Profit Margin (MRQ)Greater than02.586
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than114.932
Debt to Asset Ratio (MRQ)Less than10.048
Debt to Equity Ratio (MRQ)Less than10.050
Return on Equity (MRQ)Greater than0.150.097
Return on Assets (MRQ)Greater than0.050.092
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of TegoScience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.210
Ma 20Greater thanMa 5015,982.500
Ma 50Greater thanMa 10015,729.200
Ma 100Greater thanMa 20017,015.500
OpenGreater thanClose14,980.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About TegoScience Inc

TegoScience Inc. produces and sells wound-healing skin cell therapy products from human epithelial cells in South Korea. The company's products include Holoderm, Kaloderm, and Rosmir. It also provides Neoderm, contract research, and Skinbank services. The company was founded in 2001 and is based in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-19 09:47:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Tegoscience earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Tegoscience to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 258.6% means that ₩2.59 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TegoScience Inc:

  • The MRQ is 258.6%. The company is making a huge profit. +2
  • The TTM is 39.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ258.6%TTM39.0%+219.6%
TTM39.0%YOY-16.0%+54.9%
TTM39.0%5Y9.3%+29.6%
5Y9.3%10Y-1.7%+11.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ258.6%9.8%+248.8%
TTM39.0%9.5%+29.5%
YOY-16.0%9.9%-25.9%
5Y9.3%12.9%-3.6%
10Y-1.7%12.6%-14.3%
4.3.1.2. Return on Assets

Shows how efficient Tegoscience is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tegoscience to the Pharmaceuticals industry mean.
  • 9.2% Return on Assets means that Tegoscience generated ₩0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TegoScience Inc:

  • The MRQ is 9.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.2%TTM1.5%+7.7%
TTM1.5%YOY-0.6%+2.2%
TTM1.5%5Y0.4%+1.1%
5Y0.4%10Y0.0%+0.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ9.2%3.6%+5.6%
TTM1.5%3.5%-2.0%
YOY-0.6%5.3%-5.9%
5Y0.4%5.9%-5.5%
10Y0.0%4.9%-4.9%
4.3.1.3. Return on Equity

Shows how efficient Tegoscience is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tegoscience to the Pharmaceuticals industry mean.
  • 9.7% Return on Equity means Tegoscience generated ₩0.10 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TegoScience Inc:

  • The MRQ is 9.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ9.7%TTM1.6%+8.1%
TTM1.6%YOY-0.7%+2.3%
TTM1.6%5Y0.5%+1.1%
5Y0.5%10Y-0.1%+0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7%4.6%+5.1%
TTM1.6%4.6%-3.0%
YOY-0.7%8.2%-8.9%
5Y0.5%9.1%-8.6%
10Y-0.1%10.3%-10.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of TegoScience Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Tegoscience is operating .

  • Measures how much profit Tegoscience makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tegoscience to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TegoScience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.7%+0.7%
TTM-5Y2.1%-2.1%
5Y2.1%10Y4.4%-2.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY-0.7%12.4%-13.1%
5Y2.1%8.6%-6.5%
10Y4.4%12.1%-7.7%
4.3.2.2. Operating Ratio

Measures how efficient Tegoscience is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 0.58 means that the operating costs are ₩0.58 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of TegoScience Inc:

  • The MRQ is 0.577. The company is very efficient in keeping operating costs low. +2
  • The TTM is 1.405. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.577TTM1.405-0.828
TTM1.405YOY1.071+0.334
TTM1.4055Y0.688+0.717
5Y0.68810Y0.768-0.080
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5771.225-0.648
TTM1.4051.220+0.185
YOY1.0711.311-0.240
5Y0.6881.249-0.561
10Y0.7681.240-0.472
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of TegoScience Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Tegoscience is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 14.93 means the company has ₩14.93 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of TegoScience Inc:

  • The MRQ is 14.932. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.425. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.932TTM12.425+2.507
TTM12.425YOY10.095+2.330
TTM12.4255Y17.690-5.265
5Y17.69010Y18.450-0.760
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ14.9322.213+12.719
TTM12.4252.234+10.191
YOY10.0952.028+8.067
5Y17.6902.199+15.491
10Y18.4501.995+16.455
4.4.3.2. Quick Ratio

Measures if Tegoscience is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tegoscience to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TegoScience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.957-6.957
TTM6.957YOY13.205-6.248
TTM6.9575Y17.091-10.135
5Y17.09110Y14.772+2.319
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM6.9570.973+5.984
YOY13.2051.515+11.690
5Y17.0911.591+15.500
10Y14.7721.399+13.373
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of TegoScience Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Tegoscience assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tegoscience to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.05 means that Tegoscience assets are financed with 4.8% credit (debt) and the remaining percentage (100% - 4.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TegoScience Inc:

  • The MRQ is 0.048. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.054. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.048TTM0.054-0.007
TTM0.054YOY0.058-0.004
TTM0.0545Y0.041+0.013
5Y0.04110Y0.085-0.044
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0480.345-0.297
TTM0.0540.339-0.285
YOY0.0580.333-0.275
5Y0.0410.315-0.274
10Y0.0850.339-0.254
4.5.4.2. Debt to Equity Ratio

Measures if Tegoscience is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tegoscience to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 5.0% means that company has ₩0.05 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TegoScience Inc:

  • The MRQ is 0.050. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.057. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.057-0.007
TTM0.057YOY0.062-0.004
TTM0.0575Y0.043+0.014
5Y0.04310Y0.128-0.084
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0500.547-0.497
TTM0.0570.547-0.490
YOY0.0620.499-0.437
5Y0.0430.476-0.433
10Y0.1280.548-0.420
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Tegoscience generates.

  • Above 15 is considered overpriced but always compare Tegoscience to the Pharmaceuticals industry mean.
  • A PE ratio of 7.93 means the investor is paying ₩7.93 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TegoScience Inc:

  • The EOD is 6.221. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.933. Based on the earnings, the company is underpriced. +1
  • The TTM is 29.783. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.221MRQ7.933-1.712
MRQ7.933TTM29.783-21.850
TTM29.783YOY-83.609+113.392
TTM29.7835Y46.321-16.538
5Y46.32110Y121.089-74.768
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD6.22127.863-21.642
MRQ7.93329.844-21.911
TTM29.78327.532+2.251
YOY-83.60923.102-106.711
5Y46.32127.577+18.744
10Y121.08929.248+91.841
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TegoScience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-154.881+154.881
TTM-154.881YOY-15.246-139.634
TTM-154.8815Y54.855-209.736
5Y54.85510Y91.697-36.842
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-154.88129.447-184.328
YOY-15.24626.360-41.606
5Y54.85531.734+23.121
10Y91.69734.357+57.340
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Tegoscience is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 3.07 means the investor is paying ₩3.07 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of TegoScience Inc:

  • The EOD is 2.411. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.074. Based on the equity, the company is fair priced.
  • The TTM is 2.763. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.411MRQ3.074-0.663
MRQ3.074TTM2.763+0.312
TTM2.763YOY2.163+0.600
TTM2.7635Y3.393-0.630
5Y3.39310Y7.133-3.741
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD2.4114.659-2.248
MRQ3.0743.381-0.307
TTM2.7633.209-0.446
YOY2.1632.597-0.434
5Y3.3933.278+0.115
10Y7.1334.179+2.954
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -1,127,3511,028,799-98,553-444,385-542,938-305,361-848,2982,198,1871,349,889



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets53,180,786
Total Liabilities2,543,845
Total Stockholder Equity50,786,188
 As reported
Total Liabilities 2,543,845
Total Stockholder Equity+ 50,786,188
Total Assets = 53,180,786

Assets

Total Assets53,180,786
Total Current Assets32,344,820
Long-term Assets20,835,966
Total Current Assets
Total Current Assets  (as reported)32,344,820
Total Current Assets  (calculated)0
+/- 32,344,820
Long-term Assets
Long-term Assets  (as reported)20,835,966
Long-term Assets  (calculated)0
+/- 20,835,966

Liabilities & Shareholders' Equity

Total Current Liabilities2,166,076
Long-term Liabilities377,769
Total Stockholder Equity50,786,188
Total Current Liabilities
Total Current Liabilities  (as reported)2,166,076
Total Current Liabilities  (calculated)0
+/- 2,166,076
Long-term Liabilities
Long-term Liabilities  (as reported)377,769
Long-term Liabilities  (calculated)0
+/- 377,769
Total Stockholder Equity
Total Stockholder Equity (as reported)50,786,188
Total Stockholder Equity (calculated)0
+/- 50,786,188
Other
Common Stock Shares Outstanding 8,007
Net Invested Capital 50,786,188
Net Working Capital 30,178,744



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
45,247,953
46,491,670
47,517,064
48,388,757
48,140,290
48,227,032
48,350,073
47,562,132
47,524,882
48,035,577
48,466,010
0
48,694,624
49,092,181
50,488,320
50,401,650
49,938,945
49,854,478
49,661,620
51,003,886
50,526,955
50,875,572
51,251,128
51,362,834
51,536,147
50,277,120
50,457,846
48,910,276
48,279,019
53,180,786
53,180,78648,279,01948,910,27650,457,84650,277,12051,536,14751,362,83451,251,12850,875,57250,526,95551,003,88649,661,62049,854,47849,938,94550,401,65050,488,32049,092,18148,694,624048,466,01048,035,57747,524,88247,562,13248,350,07348,227,03248,140,29048,388,75747,517,06446,491,67045,247,953
   > Total Current Assets 
0
0
26,586,637
24,438,198
24,323,604
24,521,608
24,962,682
25,180,559
25,296,384
25,874,468
26,473,202
26,404,754
25,940,089
26,437,296
27,659,229
28,098,598
27,523,774
25,024,152
24,951,548
26,532,796
26,214,307
26,684,503
26,894,831
27,451,610
27,691,950
26,413,504
26,322,890
28,231,331
27,605,936
32,344,820
32,344,82027,605,93628,231,33126,322,89026,413,50427,691,95027,451,61026,894,83126,684,50326,214,30726,532,79624,951,54825,024,15227,523,77428,098,59827,659,22926,437,29625,940,08926,404,75426,473,20225,874,46825,296,38425,180,55924,962,68224,521,60824,323,60424,438,19826,586,63700
       Cash And Cash Equivalents 
0
0
599,419
429,096
484,516
336,413
785,148
1,258,586
1,021,403
1,072,813
1,330,916
0
912,858
2,189,039
1,745,798
1,612,452
1,493,482
330
330
0
0
168
168
807,892
1,973,326
1,987,312
1,413,694
2,114,693
1,994,340
0
01,994,3402,114,6931,413,6941,987,3121,973,326807,892168168003303301,493,4821,612,4521,745,7982,189,039912,85801,330,9161,072,8131,021,4031,258,586785,148336,413484,516429,096599,41900
       Short-term Investments 
0
0
14,000,000
16,000,000
16,000,000
5,000,000
5,000,000
10,000,000
10,000,000
7,000,000
7,000,000
0
0
0
0
0
21,958,316
19,414,501
19,145,118
18,701,431
20,500,000
21,500,000
21,500,000
21,500,000
19,300,000
19,300,000
19,690,053
18,800,000
18,800,000
0
018,800,00018,800,00019,690,05319,300,00019,300,00021,500,00021,500,00021,500,00020,500,00018,701,43119,145,11819,414,50121,958,316000007,000,0007,000,00010,000,00010,000,0005,000,0005,000,00016,000,00016,000,00014,000,00000
       Net Receivables 
2,535,833
2,907,648
3,437,965
3,100,329
2,554,652
2,894,836
3,105,927
2,695,444
2,526,282
2,720,920
2,977,819
2,686,973
2,845,762
3,294,598
4,667,278
3,945,747
2,861,758
2,640,374
2,567,050
4,236,572
3,621,588
2,976,533
3,066,105
3,362,068
3,168,096
3,034,288
3,584,657
2,987,086
2,353,139
0
02,353,1392,987,0863,584,6573,034,2883,168,0963,362,0683,066,1052,976,5333,621,5884,236,5722,567,0502,640,3742,861,7583,945,7474,667,2783,294,5982,845,7622,686,9732,977,8192,720,9202,526,2822,695,4443,105,9272,894,8362,554,6523,100,3293,437,9652,907,6482,535,833
       Other Current Assets 
488,818
335,500
432,226
163,737
273,308
93,025
114,492
103,392
105,155
230,704
177,366
273,060
261,684
110,806
60,986
181,465
135,878
0
0
56,870
62,248
49,932
252,144
-1
0
0
137,595
0
0
0
000137,59500-1252,14449,93262,24856,87000135,878181,46560,986110,806261,684273,060177,366230,704105,155103,392114,49293,025273,308163,737432,226335,500488,818
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,911,224
23,844,196
23,863,616
24,134,956
20,678,944
20,673,084
20,835,966
20,835,96620,673,08420,678,94424,134,95623,863,61623,844,19623,911,22400000000000000000000000
       Property Plant Equipment 
9,517,941
11,792,432
15,709,925
19,192,339
19,392,278
19,348,742
19,278,428
19,201,904
19,082,590
18,989,150
18,882,756
18,775,414
18,640,072
18,580,388
18,496,912
17,794,528
17,660,272
17,524,658
17,416,077
17,260,206
17,152,139
17,019,157
16,904,994
16,774,368
16,711,816
16,699,464
16,612,974
16,485,274
16,360,694
0
016,360,69416,485,27416,612,97416,699,46416,711,81616,774,36816,904,99417,019,15717,152,13917,260,20617,416,07717,524,65817,660,27217,794,52818,496,91218,580,38818,640,07218,775,41418,882,75618,989,15019,082,59019,201,90419,278,42819,348,74219,392,27819,192,33915,709,92511,792,4329,517,941
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000010000000000
       Intangible Assets 
1,172,653
70,097
68,475
115,313
901,899
102,291
97,203
92,266
87,330
82,391
77,455
0
610,746
630,153
681,165
683,724
819,056
851,028
863,922
877,381
879,263
885,119
1,158,565
1,271,783
1,264,858
1,401,100
1,861,055
1,956,086
2,085,496
0
02,085,4961,956,0861,861,0551,401,1001,264,8581,271,7831,158,565885,119879,263877,381863,922851,028819,056683,724681,165630,153610,746077,45582,39187,33092,26697,203102,291901,899115,31368,47570,0971,172,653
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,366
1
1
0
01153,36600000000000000000000000000
> Total Liabilities 
18,912,022
22,895,872
21,379,514
11,818,571
1,229,173
1,072,961
1,060,961
788,963
937,231
746,644
889,508
0
900,863
929,882
1,685,799
1,413,251
1,383,364
1,689,248
1,674,967
2,529,562
2,551,805
2,469,092
2,646,381
2,766,461
3,328,733
3,126,975
3,200,471
2,584,660
2,588,751
2,543,845
2,543,8452,588,7512,584,6603,200,4713,126,9753,328,7332,766,4612,646,3812,469,0922,551,8052,529,5621,674,9671,689,2481,383,3641,413,2511,685,799929,882900,8630889,508746,644937,231788,9631,060,9611,072,9611,229,17311,818,57121,379,51422,895,87218,912,022
   > Total Current Liabilities 
827,114
2,602,542
901,634
11,714,262
1,123,752
966,421
953,272
788,963
933,625
720,537
866,756
632,015
782,798
790,371
1,542,562
1,285,126
1,278,730
1,660,162
1,654,186
2,415,093
2,418,573
2,317,559
2,454,085
2,607,186
2,998,768
2,735,155
2,784,809
2,180,633
2,231,766
2,166,076
2,166,0762,231,7662,180,6332,784,8092,735,1552,998,7682,607,1862,454,0852,317,5592,418,5732,415,0931,654,1861,660,1621,278,7301,285,1261,542,562790,371782,798632,015866,756720,537933,625788,963953,272966,4211,123,75211,714,262901,6342,602,542827,114
       Short-term Debt 
0
0
11,653,166
3,924,088
69,103
70,221
0
0
0
74,932
0
0
0
0
0
0
140,000
490,000
664,000
1,000,000
1,100,000
1,100,000
1,100,000
1,100,000
0
0
0
0
0
0
0000001,100,0001,100,0001,100,0001,100,0001,000,000664,000490,000140,00000000074,93200070,22169,1033,924,08811,653,16600
       Short Long Term Debt 
0
0
11,653,166
3,924,088
69,103
70,221
0
0
0
74,932
0
0
0
0
0
0
0
0
0
0
0
0
0
1,100,000
1,395,000
1,380,000
1,365,000
1,350,000
1,345,000
0
01,345,0001,350,0001,365,0001,380,0001,395,0001,100,000000000000000074,93200070,22169,1033,924,08811,653,16600
       Accounts payable 
24,230
14,601
28,298
13,372
33,636
17,544
9,750
25,776
251,677
16,730
29,819
19,106
35,360
29,554
73,472
24,320
14,802
0
0
17,552
103,431
35,203
26,154
51,180
52,049
34,530
46,107
28,176
36,088
0
036,08828,17646,10734,53052,04951,18026,15435,203103,43117,5520014,80224,32073,47229,55435,36019,10629,81916,730251,67725,7769,75017,54433,63613,37228,29814,60124,230
       Other Current Liabilities 
802,884
1,670,063
873,336
7,776,802
1,090,116
809,189
765,812
636,129
504,717
519,495
779,301
468,557
572,073
634,746
1,238,424
1,119,500
927,484
0
0
1,273,285
1,041,775
1,075,294
1,141,466
1
1
0
404,556
0
-1
0
0-10404,5560111,141,4661,075,2941,041,7751,273,28500927,4841,119,5001,238,424634,746572,073468,557779,301519,495504,717636,129765,812809,1891,090,1167,776,802873,3361,670,063802,884
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276,622
329,965
391,820
415,662
404,027
356,984
377,769
377,769356,984404,027415,662391,820329,965276,62200000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
26,381
53,013
60,817
0
34,993
26,953
20,842
14,674
25,754
18,081
28,709
26,149
0
0
0
0
0
0
00000026,14928,70918,08125,75414,67420,84226,95334,993060,81753,01326,381000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
-11,653,166
-3,924,088
-69,103
-70,221
0
0
0
-74,932
0
0
0
0
0
0
-140,000
-490,000
-664,000
-1,000,000
-1,100,000
-1,100,000
-1,100,000
-1,049,072
106,012
176,095
205,636
194,501
183,244
0
0183,244194,501205,636176,095106,012-1,049,072-1,100,000-1,100,000-1,100,000-1,000,000-664,000-490,000-140,000000000-74,932000-70,221-69,103-3,924,088-11,653,16600
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
-1
0
0
00-1000100000000000000000000000
       Deferred Long Term Liability 
0
0
1,195,282
801,122
0
1,004,282
1,086,205
333,512
334,840
423,675
366,334
399,941
527,368
527,968
527,968
529,915
668,205
0
0
721,502
731,471
744,449
1,025,774
0
0
0
0
0
0
0
00000001,025,774744,449731,471721,50200668,205529,915527,968527,968527,368399,941366,334423,675334,840333,5121,086,2051,004,2820801,1221,195,28200
> Total Stockholder Equity
26,264,529
23,533,406
26,078,700
36,515,395
46,864,972
47,117,038
47,262,058
46,680,114
46,501,105
47,278,697
47,482,184
0
47,793,761
48,162,298
48,802,521
48,988,399
48,555,582
48,165,230
47,986,653
48,474,324
47,975,150
48,406,480
48,604,746
48,596,373
48,329,321
47,279,570
47,392,726
46,463,499
45,834,505
50,786,188
50,786,18845,834,50546,463,49947,392,72647,279,57048,329,32148,596,37348,604,74648,406,48047,975,15048,474,32447,986,65348,165,23048,555,58248,988,39948,802,52148,162,29847,793,761047,482,18447,278,69746,501,10546,680,11447,262,05847,117,03846,864,97236,515,39526,078,70023,533,40626,264,529
   Common Stock
1,851,429
1,851,428
1,865,834
1,967,717
2,018,659
2,018,659
4,037,317
4,037,317
4,037,317
4,042,817
4,042,817
4,042,817
4,042,817
4,042,817
4,042,817
4,042,817
4,054,417
4,054,417
4,054,417
4,054,417
4,054,417
4,054,417
4,054,417
4,054,417
0
0
0
0
0
0
0000004,054,4174,054,4174,054,4174,054,4174,054,4174,054,4174,054,4174,054,4174,042,8174,042,8174,042,8174,042,8174,042,8174,042,8174,042,8174,037,3174,037,3174,037,3172,018,6592,018,6591,967,7171,865,8341,851,4281,851,429
   Retained Earnings 
2,829
67,180
85,347
127,335
157,885
7,272,425
7,404,536
4,025,682
3,861,935
4,327,784
4,545,063
4,881,260
5,134,655
5,666,164
6,306,387
6,733,375
6,148,257
5,757,905
5,848,711
6,773,217
6,481,318
6,912,649
7,098,468
7,037,729
6,716,163
5,611,291
5,694,040
4,715,216
4,057,626
0
04,057,6264,715,2165,694,0405,611,2916,716,1637,037,7297,098,4686,912,6496,481,3186,773,2175,848,7115,757,9056,148,2576,733,3756,306,3875,666,1645,134,6554,881,2604,545,0634,327,7843,861,9354,025,6827,404,5367,272,425157,885127,33585,34767,1802,829
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
38,705,070
38,705,070
38,705,070
38,705,070
39,366,696
39,366,696
39,366,696
39,448,948
39,448,948
39,448,948
39,448,948
39,448,948
0
0
0
0
0
0
00000039,448,94839,448,94839,448,94839,448,94839,448,94839,366,69639,366,69639,366,69638,705,07038,705,07038,705,07038,705,070000000000000
   Treasury Stock00000000000-1,351,631-1,082,248-1,082,248-682,098-440,987-440,987-278,015000000000000
   Other Stockholders Equity 
0
0
85,347
127,335
157,886
196,822
236,186
275,551
260,289
203,025
189,234
189,234
189,234
189,234
189,234
189,234
68,460
-13,792
-13,792
-13,792
-13,792
-13,792
-1,346
-13,792
0
0
0
0
0
0
000000-13,792-1,346-13,792-13,792-13,792-13,792-13,79268,460189,234189,234189,234189,234189,234189,234203,025260,289275,551236,186196,822157,886127,33585,34700



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,772,409
Cost of Revenue-2,468,275
Gross Profit5,304,1335,304,133
 
Operating Income (+$)
Gross Profit5,304,133
Operating Expense-8,957,142
Operating Income-1,184,733-3,653,008
 
Operating Expense (+$)
Research Development2,576,116
Selling General Administrative1,768,109
Selling And Marketing Expenses0
Operating Expense8,957,1424,344,224
 
Net Interest Income (+$)
Interest Income813,494
Interest Expense-62,385
Other Finance Cost-0
Net Interest Income751,109
 
Pretax Income (+$)
Operating Income-1,184,733
Net Interest Income751,109
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,562,792-1,184,733
EBIT - interestExpense = -62,385
-2,322,513
-2,260,128
Interest Expense62,385
Earnings Before Interest and Taxes (EBIT)0-2,500,407
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-2,562,792
Tax Provision--219,743
Net Income From Continuing Ops-2,343,050-2,343,050
Net Income-2,322,513
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-751,109
 

Technical Analysis of Tegoscience
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tegoscience. The general trend of Tegoscience is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tegoscience's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TegoScience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 17,550 < 17,860 < 19,000.

The bearish price targets are: 13,980 > 10,720 > 10,710.

Tweet this
TegoScience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TegoScience Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TegoScience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TegoScience Inc. The current macd is -323.87745019.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tegoscience price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tegoscience. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tegoscience price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TegoScience Inc Daily Moving Average Convergence/Divergence (MACD) ChartTegoScience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TegoScience Inc. The current adx is 20.99.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tegoscience shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
TegoScience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TegoScience Inc. The current sar is 14,607.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
TegoScience Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TegoScience Inc. The current rsi is 40.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
TegoScience Inc Daily Relative Strength Index (RSI) ChartTegoScience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TegoScience Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tegoscience price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
TegoScience Inc Daily Stochastic Oscillator ChartTegoScience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TegoScience Inc. The current cci is -73.27173842.

TegoScience Inc Daily Commodity Channel Index (CCI) ChartTegoScience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TegoScience Inc. The current cmo is -27.75285666.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
TegoScience Inc Daily Chande Momentum Oscillator (CMO) ChartTegoScience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TegoScience Inc. The current willr is -81.50684932.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
TegoScience Inc Daily Williams %R ChartTegoScience Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TegoScience Inc.

TegoScience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TegoScience Inc. The current atr is 833.30.

TegoScience Inc Daily Average True Range (ATR) ChartTegoScience Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TegoScience Inc. The current obv is 2,165,747.

TegoScience Inc Daily On-Balance Volume (OBV) ChartTegoScience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TegoScience Inc. The current mfi is 20.24.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TegoScience Inc Daily Money Flow Index (MFI) ChartTegoScience Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TegoScience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

TegoScience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TegoScience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.210
Ma 20Greater thanMa 5015,982.500
Ma 50Greater thanMa 10015,729.200
Ma 100Greater thanMa 20017,015.500
OpenGreater thanClose14,980.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Tegoscience with someone you think should read this too:
  • Are you bullish or bearish on Tegoscience? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tegoscience? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TegoScience Inc

I send you an email if I find something interesting about TegoScience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TegoScience Inc.

Receive notifications about TegoScience Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.